Mutations that upregulate the pathway, including BRAF (B rapidly accelerated fibrosarcoma kinase), RAS (rat sarcoma virus small GTPase), and NF1 (neurofibromin 1), are found in more than 80% of cutaneous melanomas [8]. This evidence concerns the gene NF1 and cutaneous melanoma.